Literature DB >> 15883382

Serum IgG mediates mucosal immunity against rotavirus infection.

Larry E Westerman1, Harold M McClure, Baoming Jiang, Jeffrey W Almond, Roger I Glass.   

Abstract

We evaluated the protective role of passively transferred circulating antibodies in protecting non-human primates against experimental rotavirus infection. Pooled sera with rotavirus-specific IgG titers that were either high (1:10,000), intermediate (1:300), or negative (< 1:25) were infused i.v. into naive pigtailed macaques (ages 3-6 months). Rotavirus-specific IgG could be detected in the sera at 18 h in all animals infused with antibody-containing serum, and fecal IgG titers could be detected only in animals given high-titer pooled sera. When orally challenged with 10(6) fluorescent-forming units of a simian rotavirus strain, YK-1, at 18 h after serum transfer, control animals shed virus starting 1-3 days after challenge and continued to shed virus at high titers for 6-8 days, whereas passively immunized macaques did not shed virus or had delayed shedding at low titers for only a limited time. The observation that passively transferred antibodies can suppress or delay viral infection in rotavirus-challenged pigtailed macaques has important implications for the design and testing of parenteral candidate rotavirus vaccines.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15883382      PMCID: PMC1129131          DOI: 10.1073/pnas.0502437102

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  42 in total

Review 1.  Immunoglobulin transport across polarized epithelial cells.

Authors:  Raul Rojas; Gerard Apodaca
Journal:  Nat Rev Mol Cell Biol       Date:  2002-12       Impact factor: 94.444

2.  Activated primary and memory CD8 T cells migrate to nonlymphoid tissues regardless of site of activation or tissue of origin.

Authors:  David Masopust; Vaiva Vezys; Edward J Usherwood; Linda S Cauley; Sara Olson; Amanda L Marzo; Richard L Ward; David L Woodland; Leo Lefrançois
Journal:  J Immunol       Date:  2004-04-15       Impact factor: 5.422

3.  Experimental infection of pigtailed macaques with a simian rotavirus, YK-1.

Authors:  Larry E Westerman; Jin Xu; Baoming Jiang; Harold M McClure; Roger I Glass
Journal:  J Med Virol       Date:  2005-04       Impact factor: 2.327

4.  Intussusception among infants given an oral rotavirus vaccine.

Authors:  T V Murphy; P M Gargiullo; M S Massoudi; D B Nelson; A O Jumaan; C A Okoro; L R Zanardi; S Setia; E Fair; C W LeBaron; M Wharton; J R Livengood; J R Livingood
Journal:  N Engl J Med       Date:  2001-02-22       Impact factor: 91.245

5.  Studies on human intestinal immunoglobulin A.

Authors:  D M Bull; J Bienenstock; T B Tomasi
Journal:  Gastroenterology       Date:  1971-03       Impact factor: 22.682

6.  Immunogenicity and protective efficacy of a formalin-inactivated rotavirus vaccine combined with lipid adjuvants.

Authors:  Kari Johansen; Ulf Schröder; Lennart Svensson
Journal:  Vaccine       Date:  2003-01-17       Impact factor: 3.641

7.  Heterologous protection induced by the inner capsid proteins of rotavirus requires transcytosis of mucosal immunoglobulins.

Authors:  Isabelle Schwartz-Cornil; Yann Benureau; Harry Greenberg; Barbara A Hendrickson; Jean Cohen
Journal:  J Virol       Date:  2002-08       Impact factor: 5.103

8.  Rotavirus infection in lambs: studies on passive protection.

Authors:  D R Snodgrass; P W Wells
Journal:  Arch Virol       Date:  1976       Impact factor: 2.574

9.  Molecular and immunological methods to detect rotavirus in formalin-fixed tissue.

Authors:  Kathleen M Tatti; Jon Gentsch; Wun-Ju Shieh; Tara Ferebee-Harris; Maureen Lynch; Joseph Bresee; Baoming Jiang; Sherif R Zaki; Roger Glass
Journal:  J Virol Methods       Date:  2002-09       Impact factor: 2.014

10.  Global illness and deaths caused by rotavirus disease in children.

Authors:  Umesh D Parashar; Erik G Hummelman; Joseph S Bresee; Mark A Miller; Roger I Glass
Journal:  Emerg Infect Dis       Date:  2003-05       Impact factor: 6.883

View more
  29 in total

Review 1.  Correlates of protection induced by vaccination.

Authors:  Stanley A Plotkin
Journal:  Clin Vaccine Immunol       Date:  2010-05-12

2.  Immunization of mice with chimeric antigens displaying selected epitopes confers protection against intestinal colonization and renal damage caused by Shiga toxin-producing Escherichia coli.

Authors:  David A Montero; Felipe Del Canto; Juan C Salazar; Sandra Céspedes; Leandro Cádiz; Mauricio Arenas-Salinas; José Reyes; Ángel Oñate; Roberto M Vidal
Journal:  NPJ Vaccines       Date:  2020-03-12       Impact factor: 7.344

3.  Rotavirus specific plasma secretory immunoglobulin in children with acute gastroenteritis and children vaccinated with an attenuated human rotavirus vaccine.

Authors:  Daniel Herrera; Camilo Vásquez; Blaise Corthésy; Manuel A Franco; Juana Angel
Journal:  Hum Vaccin Immunother       Date:  2013-07-09       Impact factor: 3.452

4.  Prevention of cholestasis in the murine rotavirus-induced biliary atresia model using passive immunization and nonreplicating virus-like particles.

Authors:  Paula M Hertel; Sue E Crawford; Brooke C Bessard; Mary K Estes
Journal:  Vaccine       Date:  2013-07-22       Impact factor: 3.641

5.  Immunomodulating dose of levamisole stimulates innate immune response and prevents intestinal damage in porcine rotavirus diarrhea: a restricted-randomized, single-blinded, and placebo-controlled clinical trial.

Authors:  Gollahalli Eregowda Chethan; Ujjwal Kumar De; Jugal Garkhal; Shubhankar Sircar; Yash Pal Singh Malik; Nihar Ranjan Sahoo; Med Ram Verma
Journal:  Trop Anim Health Prod       Date:  2019-02-21       Impact factor: 1.559

Review 6.  Rotavirus vaccines: an overview.

Authors:  Penelope H Dennehy
Journal:  Clin Microbiol Rev       Date:  2008-01       Impact factor: 26.132

7.  Construction and characterization of human rotavirus recombinant VP8* subunit parenteral vaccine candidates.

Authors:  Xiaobo Wen; Dianjun Cao; Ronald W Jones; Jianping Li; Shousun Szu; Yasutaka Hoshino
Journal:  Vaccine       Date:  2012-08-09       Impact factor: 3.641

Review 8.  Drug and Vaccine Development for the Treatment and Prevention of Urinary Tract Infections.

Authors:  Valerie P O'Brien; Thomas J Hannan; Hailyn V Nielsen; Scott J Hultgren
Journal:  Microbiol Spectr       Date:  2016-02

9.  Field trial of a Pasteurella multocida extract vaccine in rabbits.

Authors:  Mark A Suckow; Rudolph W Haab; Lawrence J Miloscio; Norman B Guilloud
Journal:  J Am Assoc Lab Anim Sci       Date:  2008-01       Impact factor: 1.232

10.  Antibody is critical for the clearance of murine norovirus infection.

Authors:  Karen A Chachu; David W Strong; Anna D LoBue; Christiane E Wobus; Ralph S Baric; Herbert W Virgin
Journal:  J Virol       Date:  2008-04-16       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.